- Home
- LGHL vs VTAK Comparison
LGHL vs VTAK Comparison
Compare LGHL & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGHL
- VTAK
- Stock Information
- Founded
- LGHL 2015
- VTAK 2002
- Country
- LGHL Singapore
- VTAK United States
- Employees
- LGHL N/A
- VTAK N/A
- Industry
- LGHL Investment Bankers/Brokers/Service
- VTAK Medical/Dental Instruments
- Sector
- LGHL Finance
- VTAK Health Care
- Exchange
- LGHL Nasdaq
- VTAK Nasdaq
- Market Cap
- LGHL 4.3M
- VTAK 2.6M
- IPO Year
- LGHL N/A
- VTAK 2018
- Fundamental
- Price
- LGHL $0.12
- VTAK $0.34
- Analyst Decision
- LGHL
- VTAK
- Analyst Count
- LGHL 0
- VTAK 0
- Target Price
- LGHL N/A
- VTAK N/A
- AVG Volume (30 Days)
- LGHL 1.4M
- VTAK 158.9K
- Earning Date
- LGHL 04-29-2025
- VTAK 05-05-2025
- Dividend Yield
- LGHL N/A
- VTAK N/A
- EPS Growth
- LGHL N/A
- VTAK N/A
- EPS
- LGHL N/A
- VTAK N/A
- Revenue
- LGHL $13,659,110.00
- VTAK $399,000.00
- Revenue This Year
- LGHL N/A
- VTAK $38.46
- Revenue Next Year
- LGHL N/A
- VTAK $533.33
- P/E Ratio
- LGHL N/A
- VTAK N/A
- Revenue Growth
- LGHL 11.35
- VTAK 27.07
- 52 Week Low
- LGHL $0.10
- VTAK $0.30
- 52 Week High
- LGHL $0.97
- VTAK $8.40
- Technical
- Relative Strength Index (RSI)
- LGHL 35.82
- VTAK 40.72
- Support Level
- LGHL $0.10
- VTAK $0.31
- Resistance Level
- LGHL $0.13
- VTAK $0.35
- Average True Range (ATR)
- LGHL 0.01
- VTAK 0.03
- MACD
- LGHL -0.00
- VTAK 0.00
- Stochastic Oscillator
- LGHL 13.75
- VTAK 39.26
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.